This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Barkan, D. Articles by Green, J. E. Search for Related Content PubMed PubMed Citation Articles by Barkan, D. Articles by Green, J. E.

Inhibition of Metastatic Outgrowth from Single Dormant Tumor Cells by Targeting the Cytoskeleton

¹ Laboratory of Cell Biology and Genetics, National Cancer Institute, ² Craniofacial Developmental Biology and Regeneration Branch, National Institute of Dental and Craniofacial Research, and ³ Pediatric Oncology Branch, National Cancer Institute, NIH, Bethesda, Maryland; ⁴ Cancer Biology Department, Lawrence Berkeley National Laboratory, Berkeley, California; ⁵ Image Analysis Laboratory, Science Applications International Corporation-Frederick, National Cancer Institute at Fredrick, Fredrick, Maryland; and ⁶ London Regional Cancer Program, London, Ontario, Canada

Requests for reprints: Jeffrey E. Green, Laboratory of Cell Biology and Genetics, National Cancer Institute, NIH, Building 37, Room 4054, 37 Convent Drive, Bethesda, MD 20892. Phone: 301-435-5193; Fax: 301-496-8709; E-mail: jegreen{at}nih.gov.

Key Words: Cellular dormancy • metastasis • breast cancer • cytoskeleton • myosin light chain kinase

Metastatic breast cancer may emerge from latent tumor cells that remain dormant at disseminated sites for many years. Identifying mechanisms regulating the switch from dormancy to proliferative metastatic growth has been elusive due to the lack of experimental models of tumor cell dormancy. We characterized the in vitro growth characteristics of cells that exhibit either dormant (D2.0R, MCF-7, and K7M2AS1.46) or proliferative (D2A1, MDA-MB-231, and K7M2) metastatic behavior in vivo. Although these cells proliferate readily in two-dimensional culture, we show that when grown in three-dimensional matrix, distinct growth properties of the cells were revealed that correlate to their dormant or proliferative behavior at metastatic sites in vivo. In three-dimensional culture, cells with dormant behavior in vivo remained cell cycle arrested with elevated nuclear expression of p16 and p27. The transition from quiescence to proliferation of D2A1 cells was dependent on fibronectin production and signaling through integrin β1, leading to cytoskeletal reorganization with filamentous actin (F-actin) stress fiber formation. We show that phosphorylation of myosin light chain (MLC) by MLC kinase (MLCK) through integrin β1 is required for actin stress fiber formation and proliferative growth. Inhibition of integrin β1 or MLCK prevents transition from a quiescent to proliferative state in vitro. Inhibition of MLCK significantly reduces metastatic outgrowth in vivo. These studies show that the switch from dormancy to metastatic growth may be regulated, in part, through epigenetic signaling from the microenvironment, leading to changes in the cytoskeletal architecture of dormant cells. Targeting this process may provide therapeutic strategies for inhibition of the dormant-to-proliferative metastatic switch. [Cancer Res 2008;68(15):6241–50]

This article has been cited by other articles:

				T. Shibue and R. A. Weinberg Integrin {beta}1-focal adhesion kinase signaling directs the proliferation of metastatic cancer cells disseminated in the lungs PNAS, June 23, 2009; 106(25): 10290 - 10295. [Abstract] [Full Text] [PDF]

				D. R. Welch, C. R. Cooper, D. R. Hurst, C. C. Lynch, M. D. Martin, K. S. Vaidya, M. N. VanSaun, and A. M. Mastro Metastasis Research Society-American Association for Cancer Research Joint Conference on Metastasis Cancer Res., December 1, 2008; 68(23): 9578 - 9582. [Full Text] [PDF]